Trinity Biotech reported $22.63M in Operating Expenses for its fiscal quarter ending in December of 2024.


Operating Expenses Change Date
Abbott USD 9.07B 369M Jun/2025
Bayer EUR 10.73B 688M Jun/2025
Bio-Rad Laboratories USD 574.5M 12.8M Jun/2025
EDAP TMS EUR 24.06M 5.12M Dec/2024
J&J USD 16.8B 8.54B Jun/2025
Roche Holding CHF 11.43B 1.48B Dec/2024
Siemens EUR 16.62B 469M Jun/2025
Thermo Fisher Scientific USD 8.94B 291M Jun/2025
Tosoh JPY 229.05B 12.14B Jun/2025
Trinity Biotech USD 22.63M 4.92M Dec/2024
Veracyte USD 115.85M 2.54M Jun/2025